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Serotonin transporterEcstasy or 3,4-methylenedioxymethamphetamine (MDMA) is a frequently (ab)used recreational drug for its
acute euphoric effects but on the long-term may cause neurotoxic damage to serotonin (5-hydroxytrypta-
mine; 5-HT) nerve endings in the brain. Since decreased brain 5-HT function has been strongly associated
with several impulse control disorders like hostility and violent aggression, ecstasy users might be at risk
developing this form of psychopathology. The present study examined the ability of a MDMA administration
protocol (3×6 mg/kg, with 3 h intervals at 25 ºC ambient temperature), that previously was shown to
partially deplete brain serotonin levels, to increase offensive aggressive behavior in male Wild-type
Groningen (WTG) rats. This rat strain is known for its broad individual variation in offensive aggression.
Resident-intruder aggression was assessed 5 days before and 23 days after MDMA administration. On day 28,
MDMA neurotoxicity to 5-HT nerve terminals was assessed by quantiﬁcation of serotonin reuptake
transporter (SERT) immuno-positive axons in deﬁned brain regions. Based on their expressed aggression
level in the initial aggression test, rats were divided into low (b10% aggression), high (N50% aggression) or
medium aggressive (10–50%) groups. The study demonstrated that MDMA treatment increased aggressive-
ness in only low aggressive rats and not in medium and high aggressive animals. Irrespective of their initial
aggressiveness, MDMA signiﬁcantly reduced the number of SERT-positive axons in all animals. In conclusion,
vulnerability for increased aggression long after a single MDMA treatment is dependent on the individual's
trait aggressiveness but not on the degree of MDMA-induced serotonergic neurotoxicity.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Ecstasy or 3,4-methylenedioxymethamphetamine (MDMA), is a
serotonin releaser that is frequently used for its acute euphoric effects,
which include the feeling of more energy, increased conﬁdence,
elevated mood and affection (Liechti et al., 2001; Parrott, 2001;
Vollenweider et al., 1998). Besides the acute MDMA toxicity risks (i.e.,
severe hyperthermia and renal failure), frequent use of this drug has
given rise to concern since there is substantial evidence that MDMA
can induce persistent negative neuropsychological effects.
Several studies investigating the long-term effects of MDMAon the
serotonergic system in humans and animals have shown that MDMA
can induce a lasting decrease in serotonin (5-hydroxytryptamine; 5-
HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the brain, a
reduction in the activity of tryptophan hydroxylase (TPH) and a
reduction in the density of the serotonin transporter (Battaglia et al.,
1987; Hewitt and Green, 1994; Schmidt and Taylor, 1987; Sharkey et
al., 1991; Stone et al., 1986; Stone et al., 1987; Xie et al., 2006). Since31 503632331.
.
ll rights reserved.decreased 5-HT levels have been associated with mood disorders
including increased levels of impulsivity and aggression, ecstasy users
might be at risk developing this form of psychopathology.
Studies investigating the effect of ecstasy use in humans indeed
showed a lowering of mood starting several days after ecstasy use
(Curran et al., 2004; Curran and Travill, 1997; Parrott and Lasky, 1998;
Verheyden et al., 2002). Increased levels of hostility, impulsivity and
aggression (Curran et al., 2004; Gerra et al., 2002; Hoshi et al., 2004;
Hoshi et al., 2006; Morgan, 1998; Parrott et al., 2000; Verheyden et al.,
2002) have been reported although also negative ﬁndings are present
(Hoshi et al., 2007; McCann et al., 1994). This is consistent with the
strong evidence that serotonin plays a crucial role in the regulation of
aggressive behavior. Deﬁciencies in central serotonergic functioning
are generally associated with increased levels of aggressive behavior
in both humans and in rodents (Brown et al., 1982; Clark and
Neumaier, 2001; Coccaro, 1989).
Surprisingly, only one study has investigated the long-term effects
of MDMA on aggressive behavior in rats. No changes in aggressive
behavior were seen in rats exposed to a single injection of MDMA
21 days earlier (Kirilly et al., 2006).
In the present study we examined the ability of repeated
(“binge”) dosing of MDMA (3×6 mg/kg, with 3 h intervals at
25 ºC ambient temperature) that is known to cause a long-term
Fig. 1. A. Histogram showing the individual variation in levels of offensive aggressive
behavior towards an unfamiliar intruder rat. Insert: Levels of offensive behavior (%
duration (±S.E.M.) displayed during the ﬁrst aggression test in low (LA), medium (MA)
and high aggressive (HA) rats before receiving saline or MDMA treatment). *Pb0.05.
B. Ethogram of all rats in the resident intruder paradigm before and after receiving
either MDMA (3×6 mg/kg) or saline (3×1 ml/kg) injections (Average±s.d.).
23A.E. Wallinga et al. / European Journal of Pharmacology 618 (2009) 22–27depletion of 5-HT in various brain regions (Sanchez et al. 2004), to
increase offensive aggressive behavior in Wild-type Groningen rats
(Rattus norvegicus). This rat strain was selected for our experiments
because these animals are known to exhibit a rich repertoire of
social behavior including aggressive behavior. Furthermore, they
show a wide and consistent individual variation in aggressive
behavior, in contrast to other laboratory rat strains where the
display and individual variation of aggression is only poorly
expressed (de Boer et al., 2003).
Individual variation in personality traits like impulsiveness/aggres-
siveness seems to be an important factor determining the individual's
resilience or vulnerability to the neurotoxic and or psychopathological
effects of psychoactive drugs likeMDMA(Kellyet al., 2006; Semple et al.,
2005; White et al., 2006). A recent human study indeed showed large
inter-individual variation inMDMA-induced symptomatic neurotoxicity
dependingon their expressedpersonality traits (Reid et al., 2007). As the
individual level of aggressiveness is causally related to a differential
serotonergic neurotransmission (Koolhaas et al., 2007), we used this
measure as a dependent variable of the MDMA-induced behavioral and
neurotoxic effects.
2. Materials and methods
2.1. Subjects
This study has been approved by the animal experiments
committee of the University of Groningen (DEC protocol # 4396F).
Individual experiments were carried out in 5 different cohorts of
animals over a period of 23 months using 21 animals in each
experiment. At the moment of drug/vehicle treatment, male Wild-
type Groningen (WTG) rats (Rattus norvegicus) weighed on average
425±3.5 g. Room temperature was 21 ˚C, except during the time of
MDMA/saline administration. Light:Dark cycle was 12:12 h (lights on
at 01.00 h). Food (chow) and water were available ad libitum
throughout the whole experiment. After weaning at the age of
23 days, rats were housed in groups of six males in clear Plexiglas
cages (55×34×20 cm), until theywere tested for offensive aggression
in a standardized resident-intruder paradigm at an age of approxi-
mately 19 weeks. For this test, each rat was housed in a large cage
(80×55×40 cm) together with a female to stimulate territorial
behavior and prevent social isolation. One day before injections
animals were individually housed in clear Plexiglas cages
(38×22×15 cm) until 5 days before the last aggression test.
2.2. Aggression-test
After aweek of habituation, four resident-intruder aggression tests
were carried out on consecutive days as described previously (de Boer
et al., 2003) in order to assess animals for the display of offensive
aggressive behaviors against a male unfamiliar conspeciﬁc intruder.
Before the start of each test, the female partner was removed (approx.
30 min in advance), and an unfamiliar maleWistar rat was introduced
into the home cage of the experimental rat. The intruder Wistar rats
weighed on average 350 g (4 months old) and were socially housed.
Repeated resident-intruder test were performed to obtain a consistent
characterization of offensive aggressive trait characteristics (de Boer
et al., 2003).
During the ﬁrst three tests only the attack latency timewas scored,
and the test was terminated shortly after occurrence of the attack or
(in case of no attacks) after maximum test duration of tenmin. During
the fourth test the full behavioral proﬁle was live recorded for tenmin.
by an experienced observer blind to the treatment condition. The
duration of the following behavioral elements were scored: Offensive
aggressive behavior (clinch, lateral threat, offensive upright, keep
down, chase), social exploration (non-aggressive investigation of
opponent), non-social behavior (explore environment, rear), socialinteraction (offensive behavior+social exploration), immobility and
grooming (de Boer et al., 2003). 23 Days after the MDMA/saline
injections, a similar resident-intruder aggression test was performed
and the full behavioral proﬁle was scored.
2.3. MDMA injections
Based on the percentage of time rats spent on offensive behavior
during the initial aggression test before treatment, rats were
categorized into three different groups, namely low aggressive (LA)
(b10% offensive behavior), high aggressive (HA)(N50% offensive
behavior) and medium aggressive (MA)(between 10%–50% offensive
behavior) (Fig. 1A.). This trimodal categorization of aggressive
phenotypes is chosen based on previous ﬁndings (de Boer et al.,
2003). Within each aggression group half of the rats received MDMA
treatment and the other half vehicle. MDMA treatment consisted of
three times 6 mg/kg MDMA (±MDMA–HCl, 99,6% obtained from the
Dutch Forensic Institute, The Netherlands), administered i.p. with 3 h
interval (Sanchez et al., 2004), whereas the vehicle treatment
consisted of three times saline (1 ml/kg, i.p.) injection. All injections
were administered in the light phase, with the ﬁrst injection given 1 h
24 A.E. Wallinga et al. / European Journal of Pharmacology 618 (2009) 22–27after lights switched on. Ambient room temperature was temporarily
raised to 25 ˚C 1.5 h before the ﬁrst injection until 3 h after the last
injection.
2.4. Brain processing and immunocytochemistry
Four weeks after the injections 63 rats (the ﬁrst 3 batches) were
sacriﬁced by transcardial perfusion (under terminal anaesthesia with
pentobarbital) with heparinised saline followed by 2.5% paraformal-
dehyde and 0.05% glutaraldehyde in 0.1 M phosphate buffer. Brains
were removed and after dehydration in 30% sucrose, the left
hemisphere was cut into 40 μm sagittal sections on a cryostat
microtome. For immunocytochemistry two brain regions known to
be engaged in the regulation of aggressive behaviour were selected
(hypothalamic attack region represented in the tuber cinereum
(Hrabovszky et al., 2005) and the lateral orbital cortex (Halasz et al.,
2006) and two brain regions (hippocampus and occipital cortex)
more frequently studied in MDMA studies describing the effect of
MDMA on 5-HT axons). Two sections containing CA3 region of the
hippocampus, lateral orbital cortex and occipital cortex (sagittally
lateral 2.40 mm according to Paxinos and Watson, 1998) and two
sections containing tuber cinereum (sagittally lateral 0.90 mm) were
selected. After pre-incubation with 5% normal horse serum and 0.4%
triton-X100, sections underwent incubation with H2O2 to inactivate
endogenous peroxidase. The primary antibody applied was mouse
anti-SERT (1:1000, Biogenesis, Poole, United Kingdom; incubation at
4 ˚C for ﬁve days). As a second antibody biotinylated horse-anti-mouse
(1:500, Vector BA2001) was used. After incubation with an ABC kit
(1:500, Vector, Burlingame, United Kingdom) for 16 h, staining was
visualized with diaminobenzidine and ammonium nickel sulphate
(15 mg 3,3'-diaminobenzidine tetrahydrochloride (DAB)/100 ml Tris–
HCl, and 150 mg ammonium nickel sulphate /100 ml Tris–HCl) as
chromogen.
2.5. Quantiﬁcation
During the analysis of the brain material, the experimenter was
blind to the treatment and aggression category of the rats. SERT
immuno-positive axons were counted in the lateral orbital cortex,
tuber cinereum (hypothalamus), occipital cortex and the CA3 region
of the hippocampus with a 400x magniﬁcation using a grid
(0.0625 mm2, 100 squares). Axons that crossed the vertical and
horizontal lines of every other line of the grid were counted.
Quantiﬁcation was performed independently by two different
persons. There were no differences in the quantiﬁcation between
both persons.
2.6. Data analysis
SPSS 14.0 for Windows was employed to analyze the data
statistically. Initially each behavioral category and attack latency
time was analyzed by a repeated-measurements ANOVA with treat-
ment (2 levels) and test as the within-subject repeated measure-
ments factor. The difference in behavior of each behavioral category
between the ﬁrst and the second resident-intruder test was
analyzed by a two-way ANOVA with treatment (2 levels) and ag-
gression phenotype (3 levels) as between-subject factors. In case
of signiﬁcant main and/or interaction effects, post hoc analyses
were performed using a one-way ANOVA or Student's t-test. The
immunocytochemistry data were analyzed per brain area, using a
two-way ANOVA, with treatment (2 levels) and aggression pheno-
type (3 levels) as between-subject factors. When a signiﬁcant
interactionwas found, the effect of the treatment within the deﬁned
aggression groups was analyzed with a Student's t-test. The effect of
aggressionwithin the deﬁned treatment groups was analyzed with a
one-way ANOVA.3. Results
3.1. Behaviour: individual differences in aggression and distributions of
aggression scores
As commonly seen in our WTG rat strain, individual male resident
rats differ widely in their level of species-typical offensive aggression
expressed towards an unfamiliar intruder male, ranging from no overt
aggression at all to very high levels of intense and incessant patterns
of aggressive behaviour. Fig. 1A shows the distribution of all animals
over the various offensive aggression score classes. Although all
classes are represented, it is obvious that the individual behavioural
scores are certainly not normally distributed (Shapiro–Wilkinson test
for normality revealed signiﬁcant deviation from a normal distribu-
tion). Based on the similarity of the previously described trimodal
distribution pattern of aggressive phenotypes (de Boer et al., 2003),
rats were categorized into low aggression (24% of the animals
showing b10% offense), high aggressive (45% showing N50% offense)
and medium aggressive (31 % of the animals showing between 10 and
50% offense) (Fig. 1A).
3.2. MDMA treatment
Three weeks after MDMA-treatment, no signiﬁcant changes in the
level of aggressiveness or any of the other scored behavioral indices
(e.g., no main treatment effects for offensive behavior (F(1,98)=
1.976; P=0.163) and latency to attack ( F(1,98)=0.090; P=0.765)
were noted in the total group (n=53) of drug-treated animals as
compared to either their pre-treatment offensiveness or the vehicle-
treated group (n=51)( Fig. 1B).
However, when the individual level of aggressivenesswas taken into
account, analyzing the changes in aggressive behavior in these rats after
MDMA treatment, two-factor ANOVA testing signiﬁcant interactions
between treatment and aggressive phenotype only for offensive
behavior (F(2,98=3.197); P=0.045). (In Table 1 the percentages of
time spent on all behaviors during the ﬁrst and the second resident-
intruder aggression test is shown). As can be seen in Fig. 2, a pronounced
increase in aggressiveness was observed after MDMA treatment in the
low aggressive animals as compared to their own pre-treatment level of
aggressive behavior (t(11)=−4.916;Pb0.001) aswell as in comparison
to the vehicle-treated low-aggressive animals (F(1,23)=6.651;
P=0.017). There were no signiﬁcant effects of MDMA treatment on
aggressive behavior (neither in attack latency time nor in total offensive
behavior) in medium and high aggressive groups of rats. Surprisingly,
irrespective of type of treatment, high aggressive animals showed
signiﬁcantly decreased levels of offensive aggression three weeks after
the vehicle- or MDMA-treatment compared to their initial pre-
treatment levels (t(46)=5.592; Pb0.001).
3.3. Immunocytochemistry
Four weeks after either vehicle or MDMA-treatment, the number
of SERT-positive axons was determined. When individual levels of
aggressiveness and treatment were taken into account, the two-factor
ANOVA revealed no signiﬁcant interaction for each of the measured
brain regions. The analysis showed that MDMA treatment reduced the
number of SERT-positive axons independent of the aggression
phenotype (Main treatment effect) in CA3 region of the hippocampus
(F(1,51)=27.580; Pb0.001), tuber cinereum (F(1,39)=4.881;
P=0.033), Lateral orbital cortex (F(1,55)=15.333, Pb0.001), Occipi-
tal cortex (F(1,53)=12.054; P=0.001) (Fig. 3).
4. Discussion
The present study demonstrates that only individuals character-
ized by low trait-like aggressiveness show a robust increase in
Table 1
Percentage time spent on behavior during resident-intruder aggression test in low-aggressive (LA), medium aggressive (MA), and high-aggressive (HA) rats.
Vehicle treated rats
1st aggression test 2nd aggression test
LA MA HA LA MA HA
Offensive aggression 1.1±0.6 29.1±2.8 71.0±2.6 14.7±6.0 49.5.1±6.0 46.8±5.2
Social exploration 11.5±1.6 11.4±2.7 3.9±0.8 13.6±2.7 7.7±1.8 5.1±0.9
Non-social exploration 52.1±6.9 31.5±3.4 17.5±1.7 37.5±4.7 25.3±2.8 30.1±3.4
Immobility 30.7±7.2 22.3±3.5 6.2±1.7 25.8±5.7 15.7±3.3 14.3±2.7
Grooming 4.6±2.5 5.4±2.4 1.2±1.0 8.4±3.9 1.9±1.1 3.6±1.3
MDMA treated rats
1st aggression test 2nd aggression test
LA MA HA LA MA HA
Offensive aggression 1.8±0.9 28.8±2.8 69.4±3.1 41.5±8.3a 38.2±6.5 51.5±5.6
Social exploration 17.9±4.4 14.7±2.1 4.1±0.7 10.0±2.3 9.2±1.8 5.4±1.7
Non-social exploration 40.5±7.0 39.8±4.2 20.2±2.9 35.1±6.2 32.9±3.2 31.6±3.9
Immobility 36.9±8.5 15.4±2.8 5.9±1.8 13.4±8.1 15.5±3.1 9.7±2.6
Grooming 2.8±1.4 1.3±0.6 0.3±0.3 0.3±0.3 4.1±2.7 1.8±0.7
The ﬁrst aggression test was 5 days prior to treatment with either vehicle or MDMA. The second aggression test was 23 days after administration of vehicle or MDMA.
Values are expressed as means±S.E.M.
a Pb0.05; MDMA 2nd aggression test versus Vehicle 1st aggression test.
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MDMA treatment is known to produce long-term damage to
serotonergic axons (Callahan et al., 2001; O'Hearn et al., 1988), an
enhanced aggressiveness is not entirely unexpected and in accor-
dance with the long-standing 5-HT deﬁciency hypothesis of aggres-
sion (Berman et al., 1997; Coccaro, 1989). This much-favoured
hypothesis proposes that basal measurements of brain 5-HT activity
are inversely correlated with indices of aggression and impulsivity
leading to the suggestion that reduced 5-HT activity might be an
important factor contributing to the expression of heightened
aggressiveness (Miczek et al., 2004). Such a link between reduced
central serotonergic function and increased aggressiveness is indeed
supported by many (Buchanan et al., 1994; Chiavegatto et al., 2001;
Gianutsos and Lal, 1975; Gibbons et al., 1978; Vergnes et al., 1986) but
not all (De Almeida et al., 2001; Sijbesma et al., 1991) pharmacolo-
gical brain serotonin depletion studies in animals.
Surprisingly, however, no effect of MDMA-treatment on levels of
aggressive behavior was seen in medium and high aggressive rats. To
exclude the possibility that in high and medium aggressive rats no
behavioral change was found because the employed MDMA regimen
did not lead to serotonergic ﬁbre loss or depletion in these rats, the
serotonergic neurotoxic proﬁle in all rats was assessed. Immuno-Fig. 2. Change in the levels of offensive aggressive behavior (% duration±S.E.M) as
displayed in low, medium and high aggressive rats that received either saline or MDMA
treatment 21 days earlier. *Pb0.05.chemical quantiﬁcation of SERT positive axons is known to be a
reliable method to determine MDMA-induced serotonergic neuro-
toxicity (Xie et al., 2006). The data revealed that our MDMA
administration regimen resulted in a similar level of serotonergic
neurotoxicity in all MDMA treated animals irrespective of their
aggressive phenotype. Thus, although serotonergic deﬁciencies are
generally implicated in the enhancement of offensive aggressive
behavior, only low aggressive rats exhibit increased levels of
aggression after the MDMA-induced 5-HT depletion.
The question why only low and not medium and high aggressive
rats increase their aggressiveness after MDMA-induced 5-HT neuro-
toxicity is not easy to answer. The differences between the three
groups of rats cannot be explained by a ceiling effect in the high
aggressive males since medium aggressive rats also do not change
their levels of aggression after MDMA treatment. It seems more likely
that the results may reﬂect true individual differences in the response
to MDMA and the underlying physiological mechanisms. Our data
showing different individual changes in aggressive behavior are
consistent with the differential response of high, medium and low
aggressive rats to 5-HT1A antagonists and selective serotonin reuptakeFig. 3. Average numbers of SERT-positive axons (±S.E.M.) in lateral orbital cortex,
occipital hippocampus and hypothalamus in low (LA), medium (MA) and high aggre-
ssive (HA) rats 28 days after saline or MDMA injections. * represents the signiﬁcant
differences (Pb0.05) between the different treatments, independent of aggression type.
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dose–response relationships in response to the serotonin 5-HT1A
receptor antagonists and SSRI's with no response in the intermediate
males (de Boer et al., 2001). However, in the present study possible
anti- or pro-aggressive effects of MDMA in the high aggressive males
may be obscured by the unusual decrease in aggression of saline
treated rats, observed in the second aggression test. This decrease was
unexpected since several prior longitudinal studies in our lab using
these WTG rats have repeatedly demonstrated that the individual
level of aggressiveness is rather consistent through time. The only
difference between this study and many of these prior studies is the
employed drug/vehicle treatment schedule under high ambient
temperature. Perhaps high aggressive animals are more sensitive to
this stressful event in that it causes a persistent change in their
tendency to behave aggressively.
Considering the othermeasured behavioral parameters, changes in
immobility levels are the most interesting to focus on. Our experiment
showed that before MDMA/saline treatment, the three aggression
categories differed also signiﬁcantly in their levels of immobility
behavior. Ourmain result that only low trait-like aggressive individuals
are vulnerable for developing 5-HT related changes in aggressive
behaviour after MDMA administration support the recent observation
in humans that individuals with high self-control become more
aggressive whereas aggressive behaviour of individuals with low self-
control changes little (Reid et al., 2007). We would like to stress the
importance of this ﬁnding because it demonstrates the necessity to
take individual variation into account in studies investigating the
behavioral changes after MDMA (ab)use.
In conclusion, our results clearly show that the vulnerability for
increased aggression long after a single MDMA treatment is dependent
on the individual's trait aggressiveness and not on the degree ofMDMA-
induced serotonergic neurotoxicity. This indicates that only low trait-
like aggressive individuals are vulnerable for developing 5-HT related
changes in aggressive behaviour afterMDMA administration. It is temp-
ting to speculate that these individuals might also be more at risk of
developing 5-HT related psychopathologies, including pathological
forms of aggressive behavior.
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